Page 22 - 2024 Taiwan Health and Welfare Report

2024 Taiwan Health and Welfare Report

Table 2-1 Incidence of Ten Leading Cancers, 2021

Male Female
Age- Age-
Standardized Standardized
No. of Incidence No. of Incidence
Rank Cancer Site Rank Cancer Site
Cases Rate Cases Rate
(Per 100,000 (Per 100,000
Population) Population)
1 Colon, rectum and anus 9,297 47.1 1 Female Breast 15,448 82.5

2 Lungs, Trachea, and 8,961 44.5 2 Lungs, Trachea, and 7,919 36.0
Bronchus Bronchus
Oral Cavity, Opharynx, Colon, rectum and
3 and Hypopharyn 7,387 40.4 3 anus 6,941 30.7

4 Liver and Intrahepatic 7,448 37.6 4 Thyroid Gland 3,497 22.1
Bile Ducts
5 Prostate Gland 7,481 35.3 5 Uterus 3,181 17.0

Liver and Intrahepatic
6 Esophagus 2,614 13.7 6 Bile Ducts 3,327 13.6
2,413
11.8
7 Stomach (2,053) (10.0) 7 Ovary, Fallopian Tube, 1,793 10.2
and Broad Ligament
8 Skin 2,127 10.3 8 Skin 1,827 7.3

1,647 7.2
9 Leukemia 1,588 10.0 9 Stomach (1,253) (5.4)

10 Non-Hodgkin 1,727 9.4 10 Non-Hodgkin 1,438 7.1
lymphoma (NHL)
lymphoma (NHL)
Total 63,723 330.8 Total 58,039 288.4

Source: Department of Health Promotion Administration, MOHW, R.O.C. (Taiwan)
Notes: 1. Cancer registry data excludes carcinoma in situ.
2. Ranked from highest to lowest by age-standardized incidence rate (per 100,000 population).
3. The age-standardized incidence rate is based on the standard world population age structure in 2000. Formula: Σ(Age-Specific
Incidence Rate x Standard Age-Specific Population)/Standard Total Population.
4. Cases of gastrointestinal stromal tumors (GIST) associated with gastric cancer have been considered as malignant tumor
reports since the diagnosis year 2020 (including High Risk GIST only before the diagnosis year 2019 required reporting). Hence,
the number of cases and standardized incidence rates for gastric cancer in the parentheses below do not include GIST cases.

2. Causes of Cancer Death
In 2023, there were 53,126 deaths due to malignant The ten leading causes of cancer death in 2023
neoplasms accounting for 25.8% of total deaths were cancers of the (1) trachea, bronchus and lung;
and a crude mortality rate of 227.6 per 100,000 (2) liver and intrahepatic bile ducts; (3) colon, rectum
population. This represented an increase of 2.2% and anus; (4) breast (female); (5) prostate; (6) oral
compared to the previous year and an increase of cavity; (7) pancreas; (8) stomach; (9) oesophagus;
17.3% compared to 2013. The standardized cancer (10) ovary. Compared to 2013, cancers of the
mortality rate in 2023 was 115.4 per 100,000 prostrate, pancreas, and ovary rose in the rankings,
population, a decrease of 0.5% compared to 2022 while cancers of the oral cavity, stomach fell. (Figure
and a decrease of 12.4% compared to 2013. 2-7).

20